NutraLife BioSciences, Inc. (NLBS)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
NutraLife BioSciences, Inc. (NLBS) with AI Score 38/100 (Weak). NutraLife BioSciences, Inc. develops, manufactures, and distributes nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026NutraLife BioSciences, Inc. (NLBS) Healthcare & Pipeline Overview
NutraLife BioSciences, Inc. focuses on the development, manufacture, and distribution of nutraceutical, dietary, wellness, and CBD products. Operating in the specialty and generic drug manufacturing sector, the company offers a diverse product line, including CBD-infused and traditional wellness items, sold through multiple channels, including online and retail partnerships.
Investment Thesis
NutraLife BioSciences, Inc. presents a speculative investment opportunity within the nutraceutical and CBD market. The company's small size and OTC listing introduce significant risk, highlighted by a negative profit margin of -930.0% and a volatile beta of -15.21. Growth hinges on successful expansion of its product lines and distribution networks, particularly in the competitive CBD market. Investors should closely monitor revenue growth, cost management, and regulatory developments affecting the CBD industry. The company's ability to achieve profitability and navigate the OTC market's challenges will be critical for long-term viability. The absence of a dividend further emphasizes the speculative nature of this investment.
Based on FMP financials and quantitative analysis
Key Highlights
- NutraLife BioSciences operates with a small team of 12 employees, indicating a lean operational structure.
- The company's gross margin stands at 13.3%, reflecting the profitability of its product sales after accounting for the cost of goods sold.
- The company's profit margin is -930.0%, indicating significant losses relative to its revenue.
- NutraLife BioSciences has a beta of -15.21, suggesting an inverse correlation to the market and high volatility.
- The company does not offer a dividend, indicating that it is reinvesting earnings back into the business.
Competitors & Peers
Strengths
- Diverse product line including nutraceutical, dietary, wellness, and CBD products.
- Multiple distribution channels including online, retail, and private label.
- Established manufacturing capabilities.
- Focus on emerging wellness market trends.
Weaknesses
- Negative profit margin indicates financial instability.
- Small company size with limited resources.
- OTC listing implies higher risk and lower liquidity.
- Dependence on evolving regulatory environment for CBD products.
Catalysts
- Upcoming: Potential regulatory changes in the CBD market could create new opportunities or challenges.
- Ongoing: Expansion of product lines and entry into new markets.
- Ongoing: Strategic partnerships with retailers and distributors.
- Upcoming: Release of new clinical studies supporting the efficacy of its products.
- Ongoing: Increased consumer awareness and demand for wellness products.
Risks
- Potential: Intense competition in the CBD and nutraceutical markets.
- Potential: Changing regulatory landscape for CBD products.
- Ongoing: Negative profit margin indicates financial instability.
- Potential: Product liability claims.
- Ongoing: Dependence on evolving consumer preferences.
Growth Opportunities
- Expansion of CBD Product Lines: The growing market for CBD products presents a significant opportunity for NutraLife BioSciences. By introducing new CBD-infused products, such as edibles, beverages, and specialized formulations, the company can attract a wider customer base. The global CBD market is projected to reach billions of dollars in the coming years, offering substantial revenue potential if NutraLife can effectively innovate and market its offerings. Timeline: Ongoing.
- Strategic Partnerships with Retailers: Collaborating with major retail chains and online marketplaces can significantly expand NutraLife BioSciences' distribution network. Securing shelf space in established stores and online platforms provides access to a larger audience and enhances brand visibility. This strategy can drive sales volume and establish a stronger market presence. The timeline for securing such partnerships typically ranges from several months to a year. Market size: National and international retail market.
- Development of Private Label Products: Offering private label manufacturing services to other companies can generate a stable revenue stream for NutraLife BioSciences. By leveraging its manufacturing capabilities, the company can produce custom formulations and branded products for other businesses, capitalizing on the growing demand for private label wellness products. Timeline: Within the next 1-2 years.
- Geographic Expansion into New Markets: Expanding into new geographic markets, both domestically and internationally, can unlock significant growth opportunities. By targeting regions with high consumer demand for wellness products and favorable regulatory environments, NutraLife BioSciences can diversify its revenue streams and reduce reliance on its existing markets. Market size: Global wellness and nutraceutical market. Timeline: 2-3 years.
- Investment in Online Marketing and E-commerce: Enhancing its online presence through targeted marketing campaigns and improvements to its e-commerce platform can drive direct-to-consumer sales. By optimizing its website for search engines, utilizing social media marketing, and implementing email marketing strategies, NutraLife BioSciences can attract new customers and increase online revenue. Market size: Global e-commerce market. Timeline: Ongoing.
Opportunities
- Expansion into new geographic markets.
- Development of innovative CBD-infused products.
- Strategic partnerships with major retailers.
- Growth in the overall wellness and nutraceutical market.
Threats
- Intense competition in the CBD and nutraceutical markets.
- Changing regulatory landscape for CBD products.
- Potential for product liability claims.
- Economic downturn impacting consumer spending on wellness products.
Competitive Advantages
- Proprietary formulations for nutraceutical and CBD products.
- Established manufacturing capabilities.
- Distribution network through online and retail channels.
- Brand recognition in the wellness market.
About NLBS
NutraLife BioSciences, Inc., established in 2010 and based in Coconut Creek, Florida, operates in the nutraceutical, dietary, wellness, and CBD product space. Originally incorporated as NutraFuels, Inc., the company rebranded in March 2019 to NutraLife BioSciences, Inc., signaling a strategic shift towards a broader wellness portfolio. The company develops, manufactures, and distributes a variety of products, including cannabinoid-rich hemp oil derived from industrial hemp, tinctures, topical lotions and oils, face creams, massage oils, nutraceutical sprays with CBD, and pet products. Additionally, NutraLife BioSciences offers skincare and sanitizer products, catering to a diverse consumer base seeking wellness and health solutions. NutraLife BioSciences sells its products through its online platform, nutralifebiosciences.com, and leverages partnerships with private label distributors, online retailers, and traditional retail outlets to expand its market reach. The company's focus on both CBD and non-CBD wellness products positions it within the evolving landscape of consumer health and alternative medicine.
What They Do
- Develops nutraceutical products.
- Manufactures dietary supplements.
- Creates wellness products.
- Produces cannabidiol (CBD) products.
- Offers cannabinoid-rich hemp oil.
- Distributes products through online and retail channels.
Business Model
- Develops and manufactures nutraceutical, dietary, wellness, and CBD products.
- Sells products directly to consumers through its website.
- Partners with private label distributors.
- Distributes products through online retailers and retail outlets.
Industry Context
NutraLife BioSciences operates within the specialty and generic drug manufacturing industry, a segment experiencing growth driven by increasing consumer interest in wellness and alternative medicine. The market for CBD products is expanding but faces regulatory uncertainty and intense competition. Companies like ACCA, ACORQ, CBDHF, CHCR, and DGCRF represent key competitors. Success in this landscape requires effective branding, product differentiation, and navigating the evolving regulatory environment surrounding CBD and nutraceutical products.
Key Customers
- Individual consumers seeking nutraceutical and wellness products.
- Private label distributors looking for product manufacturing.
- Online retailers selling health and wellness products.
- Retail outlets offering dietary supplements and CBD products.
Financials
Chart & Info
NutraLife BioSciences, Inc. (NLBS) stock price: Price data unavailable
Latest News
No recent news available for NLBS.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NLBS.
Price Targets
Wall Street price target analysis for NLBS.
MoonshotScore
What does this score mean?
The MoonshotScore rates NLBS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Edgar Ward
CEO
Edgar Ward serves as the CEO of NutraLife BioSciences, Inc. His background includes experience in managing small teams and guiding the company's strategic direction within the nutraceutical and CBD sectors. Details regarding his prior roles and educational background are not available. He is responsible for overseeing the company's operations, product development, and distribution strategies.
Track Record: Under Edgar Ward's leadership, NutraLife BioSciences has focused on expanding its product offerings and distribution channels. Key milestones include the rebranding from NutraFuels, Inc. to NutraLife BioSciences, Inc. in 2019 and the ongoing development of CBD-infused products. However, the company's financial performance remains a challenge, as evidenced by the negative profit margin.
NLBS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that NutraLife BioSciences may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater price volatility and risk compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks requires a higher degree of due diligence and risk tolerance.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Low liquidity can lead to significant price volatility.
- Higher potential for fraud or manipulation compared to exchange-listed companies.
- OTC Other status indicates the company may not meet minimum financial standards.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's capitalization structure and potential dilution.
- Monitor news and press releases for any red flags.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Company has been in operation since 2010.
- Offers a range of products across multiple categories (nutraceutical, dietary, wellness, CBD).
- Sells products through multiple distribution channels (online, retail, private label).
What Investors Ask About NutraLife BioSciences, Inc. (NLBS)
What does NutraLife BioSciences, Inc. do?
NutraLife BioSciences, Inc. is involved in the development, manufacture, and distribution of a range of health and wellness products. These include nutraceuticals, dietary supplements, and cannabidiol (CBD) products. The company's business model focuses on creating and selling these products through its own website, as well as through partnerships with private label distributors, online retailers, and traditional retail outlets, targeting consumers interested in health and wellness solutions.
What do analysts say about NLBS stock?
As of 2026-03-16, there is no available analyst coverage for NutraLife BioSciences, Inc. due to its OTC listing and small market capitalization. Key valuation metrics such as price-to-earnings ratio are not meaningful due to the company's negative profitability. Investors should conduct their own thorough research and consider the risks associated with investing in OTC stocks before making any investment decisions. The company's growth potential is tied to its ability to expand its product lines and distribution networks.
What are the main risks for NLBS?
NutraLife BioSciences faces several key risks, including intense competition in the crowded CBD and nutraceutical markets, which could pressure pricing and market share. The evolving regulatory landscape for CBD products poses a significant uncertainty, as changes in regulations could impact the legality and marketability of its products. The company's negative profit margin indicates financial instability, raising concerns about its ability to fund future growth and operations. Additionally, product liability claims and dependence on consumer preferences in the rapidly changing wellness market represent ongoing challenges.
What are the key factors to evaluate for NLBS?
NutraLife BioSciences, Inc. (NLBS) currently holds an AI score of 38/100, indicating low score. Key strength: Diverse product line including nutraceutical, dietary, wellness, and CBD products.. Primary risk to monitor: Potential: Intense competition in the CBD and nutraceutical markets.. This is not financial advice.
How frequently does NLBS data refresh on this page?
NLBS prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven NLBS's recent stock price performance?
Recent price movement in NutraLife BioSciences, Inc. (NLBS) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse product line including nutraceutical, dietary, wellness, and CBD products.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider NLBS overvalued or undervalued right now?
Determining whether NutraLife BioSciences, Inc. (NLBS) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying NLBS?
Before investing in NutraLife BioSciences, Inc. (NLBS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available for NutraLife BioSciences, Inc. due to its OTC listing.
- Information based on available sources and may not be comprehensive.